Association Between Mineralocorticoid Receptor Antagonist Use and Outcome in Myocardial Infarction Patients With Heart Failure

BACKGROUND: There are no studies of mineralocorticoid receptor antagonist (MRA) treatment examining outcome in unselected real‐life patients with myocardial infarction (MI) and heart failure (HF). There is uncertainty regarding effects of MRA in relation to left ventricular ejection fraction (LVEF)...

Descripción completa

Detalles Bibliográficos
Autores principales: Löfman, Ida, Szummer, Karolina, Olsson, Henrik, Carrero, Juan‐Jesus, Lund, Lars H., Jernberg, Tomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6064826/
https://www.ncbi.nlm.nih.gov/pubmed/29980521
http://dx.doi.org/10.1161/JAHA.118.009359

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6064826/
https://www.ncbi.nlm.nih.gov/pubmed/29980521
http://dx.doi.org/10.1161/JAHA.118.009359

Ejemplares similares